These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

237 related items for PubMed ID: 21352639

  • 1. Two-week comparison study of olopatadine hydrochloride nasal spray 0.6% versus azelastine hydrochloride nasal spray 0.1% in patients with vasomotor rhinitis.
    Lieberman P, Meltzer EO, LaForce CF, Darter AL, Tort MJ.
    Allergy Asthma Proc; 2011; 32(2):151-8. PubMed ID: 21352639
    [Abstract] [Full Text] [Related]

  • 2. Effects of olopatadine hydrochloride nasal spray 0.6% in the treatment of seasonal allergic rhinitis: a phase III, multicenter, randomized, double-blind, active- and placebo-controlled study in adolescents and adults.
    Shah SR, Nayak A, Ratner P, Roland P, Michael Wall G.
    Clin Ther; 2009 Jan; 31(1):99-107. PubMed ID: 19243710
    [Abstract] [Full Text] [Related]

  • 3. Evaluation of olopatadine hydrochloride nasal spray, 0.6%, used in combination with an intranasal corticosteroid in seasonal allergic rhinitis.
    LaForce CF, Carr W, Tilles SA, Chipps BE, Storms W, Meltzer EO, Edwards M.
    Allergy Asthma Proc; 2010 Jan; 31(2):132-40. PubMed ID: 20302683
    [Abstract] [Full Text] [Related]

  • 4. Comparative study of sensory attributes of two antihistamine nasal sprays: olopatadine 0.6% and azelastine 0.1%.
    Meltzer EO, Garadi R, Laforce C, Chadwick SJ, Berger WE, Gross G, Edwards MR, Crenshaw K, Wall GM.
    Allergy Asthma Proc; 2008 Jan; 29(6):659-68. PubMed ID: 19144261
    [Abstract] [Full Text] [Related]

  • 5. Efficacy of azelastine nasal spray in the treatment of vasomotor (perennial nonallergic) rhinitis.
    Banov CH, Lieberman P, Vasomotor Rhinitis Study Groups.
    Ann Allergy Asthma Immunol; 2001 Jan; 86(1):28-35. PubMed ID: 11206234
    [Abstract] [Full Text] [Related]

  • 6. Evaluation of olopatadine hydrochloride nasal spray, 0.6%, used in combination with an intranasal corticosteroid in seasonal allergic rhinitis.
    LaForce CF, Carr W, Tilles SA, Chipps BE, Storms W, Meltzer EO, Edwards M.
    Allergy Rhinol (Providence); 2010 Apr 01; 1(2):14. PubMed ID: 28569236
    [Abstract] [Full Text] [Related]

  • 7. Comparison of intranasal azelastine to intranasal fluticasone propionate for symptom control in moderate-to-severe seasonal allergic rhinitis.
    Carr WW, Ratner P, Munzel U, Murray R, Price D, Canonica GW, Mullol J, Virchow JC, Lieberman P, Meltzer E, Bachert C.
    Allergy Asthma Proc; 2012 Apr 01; 33(6):450-8. PubMed ID: 23127291
    [Abstract] [Full Text] [Related]

  • 8. Onset and duration of action of nasal sprays in seasonal allergic rhinitis patients: olopatadine hydrochloride versus mometasone furoate monohydrate.
    Patel D, Garadi R, Brubaker M, Conroy JP, Kaji Y, Crenshaw K, Whitling A, Wall GM.
    Allergy Asthma Proc; 2007 Apr 01; 28(5):592-9. PubMed ID: 18034980
    [Abstract] [Full Text] [Related]

  • 9. Safety and efficacy of olopatadine hydrochloride nasal spray 0.6% in pediatric subjects with allergic rhinitis.
    Berger WE, Ratner PH, Casale TB, Meltzer EO, Wall GM.
    Allergy Asthma Proc; 2009 Apr 01; 30(6):612-23. PubMed ID: 20031007
    [Abstract] [Full Text] [Related]

  • 10. Comprehensive report of the efficacy, safety, quality of life, and work impact of Olopatadine 0.6% and Olopatadine 0.4% treatment in patients with seasonal allergic rhinitis.
    Fairchild CJ, Meltzer EO, Roland PS, Wells D, Drake M, Wall GM.
    Allergy Asthma Proc; 2007 Apr 01; 28(6):716-23. PubMed ID: 18201438
    [Abstract] [Full Text] [Related]

  • 11. Open-label evaluation of azelastine nasal spray in patients with seasonal allergic rhinitis and nonallergic vasomotor rhinitis.
    Lieberman P, Kaliner MA, Wheeler WJ.
    Curr Med Res Opin; 2005 Apr 01; 21(4):611-8. PubMed ID: 15899111
    [Abstract] [Full Text] [Related]

  • 12. Safety and efficacy of olopatadine hydrochloride nasal spray for the treatment of seasonal allergic rhinitis.
    Meltzer EO, Hampel FC, Ratner PH, Bernstein DI, Larsen LV, Berger WE, Finn AF, Marple BF, Roland PS, Wall GM, Brubaker MJ, Dimas C, Potts SL, Silver LH, Barnes JR.
    Ann Allergy Asthma Immunol; 2005 Dec 01; 95(6):600-6. PubMed ID: 16400902
    [Abstract] [Full Text] [Related]

  • 13. Safety and efficacy of olopatadine hydrochloride nasal spray for the treatment of seasonal allergic rhinitis to mountain cedar.
    Ratner PH, Hampel FC, Amar NJ, van Bavel JH, Mohar D, Marple BF, Roland PS, Wall GM, Brubaker MJ, Drake M, Turner D, Silver LH.
    Ann Allergy Asthma Immunol; 2005 Nov 01; 95(5):474-9. PubMed ID: 16312171
    [Abstract] [Full Text] [Related]

  • 14. Azelastine hydrochloride: a review of pharmacology, pharmacokinetics, clinical efficacy and tolerability.
    Bernstein JA.
    Curr Med Res Opin; 2007 Oct 01; 23(10):2441-52. PubMed ID: 17723160
    [Abstract] [Full Text] [Related]

  • 15. Effectiveness of azelastine nasal spray compared with oral cetirizine in patients with seasonal allergic rhinitis.
    Corren J, Storms W, Bernstein J, Berger W, Nayak A, Sacks H, Azelastine Cetirizine Trial No. 1 (ACT 1) Study Group.
    Clin Ther; 2005 May 01; 27(5):543-53. PubMed ID: 15978303
    [Abstract] [Full Text] [Related]

  • 16. Comparison of olopatadine 0.6% nasal spray versus fluticasone propionate 50 microg in the treatment of seasonal allergic rhinitis.
    Kaliner MA, Storms W, Tilles S, Spector S, Tan R, LaForce C, Lanier BQ, Chipps B.
    Allergy Asthma Proc; 2009 May 01; 30(3):255-62. PubMed ID: 19549426
    [Abstract] [Full Text] [Related]

  • 17. Combination therapy with azelastine hydrochloride nasal spray and fluticasone propionate nasal spray in the treatment of patients with seasonal allergic rhinitis.
    Ratner PH, Hampel F, Van Bavel J, Amar NJ, Daftary P, Wheeler W, Sacks H.
    Ann Allergy Asthma Immunol; 2008 Jan 01; 100(1):74-81. PubMed ID: 18254486
    [Abstract] [Full Text] [Related]

  • 18. Safety of a novel intranasal formulation of azelastine hydrochloride and fluticasone propionate in children: A randomized clinical trial.
    Berger W, Sher E, Gawchik S, Fineman S.
    Allergy Asthma Proc; 2018 Mar 01; 39(2):110-116. PubMed ID: 29490769
    [Abstract] [Full Text] [Related]

  • 19. Vasomotor rhinitis: clinical efficacy of azelastine nasal spray in comparison with placebo.
    Gehanno P, Deschamps E, Garay E, Baehre M, Garay RP.
    ORL J Otorhinolaryngol Relat Spec; 2001 Mar 01; 63(2):76-81. PubMed ID: 11244365
    [Abstract] [Full Text] [Related]

  • 20. Efficacy and safety of azelastine nasal spray at a dose of 1 spray per nostril twice daily.
    Lumry W, Prenner B, Corren J, Wheeler W.
    Ann Allergy Asthma Immunol; 2007 Sep 01; 99(3):267-72. PubMed ID: 17910331
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 12.